A CAR T cell analysis training has been conducted at Global Research Labs in cooperation with Analysis Egypt the agent of Thermo Fisher scientific.
The hands-on training composed of theoretical and practical sections and attended by a group of Professors & researchers from National Cancer Institute. The attendees expressed their full praise for the training in terms of organization and practice.
The trainer was Dr. Nashwa El-Khazragy the managing director of Global Research Labs and the consultant of Clinical Pathology-Hematology at Ain Shams Medical Research Institute (MASRI), Faculty of Medicine, Ain Shams University.
Chimeric Antigen Receptor (CAR) T cell therapy is one of the major new developments in cancer therapy, documented by recent successes of CAR T cell therapy in fighting hematologic malignancies. The great potential of genetically modified T cells targeting diseased cells now even expands into the area of solid tumors and infectious diseases.